Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Neuroscience ; 114(1): 265-73, 2002.
Article in English | MEDLINE | ID: mdl-12207971

ABSTRACT

Amyloid deposition, neuronal dystrophy and synaptic loss are characteristic pathological features of Alzheimer's disease (AD). We have used cortical neuronal cultures to assess the dystrophic effect of fibrillar amyloid beta (Abeta) and its relationship with neurotoxicity and synaptic loss. Treatment with fibrillar Abeta led to the development of neuritic dystrophy in the majority of the neurons present in the culture. Morphometric analysis and viability assays showed that neuronal dystrophy appeared significantly earlier and at lower Abeta concentrations than neurotoxicity, suggesting that both effects are generated independently by different cellular mechanisms. The development of dystrophic features required Abeta fibril formation and did not depend on the presence of the RHDS adhesive domain in the sequence of Abeta. Finally, a dramatic reduction in the density of synaptophysin immunoreactivity was closely associated with dystrophic changes in viable neurons. These results suggest that aberrant plastic changes and loss of synaptic integrity induced by fibrillar Abeta may play a significant role in the development of AD pathology.


Subject(s)
Alzheimer Disease/metabolism , Amyloid beta-Peptides/toxicity , Cerebral Cortex/metabolism , Nerve Degeneration/physiopathology , Neurofibrils/metabolism , Neurons/metabolism , Alzheimer Disease/pathology , Alzheimer Disease/physiopathology , Amyloid beta-Peptides/metabolism , Animals , Cells, Cultured , Cerebral Cortex/pathology , Cerebral Cortex/physiopathology , Dendrites/drug effects , Dendrites/metabolism , Dendrites/pathology , Down-Regulation/drug effects , Down-Regulation/physiology , Fetus , Immunohistochemistry , Nerve Degeneration/chemically induced , Nerve Degeneration/pathology , Neural Pathways/drug effects , Neural Pathways/metabolism , Neural Pathways/pathology , Neurites/drug effects , Neurites/metabolism , Neurites/pathology , Neurofibrils/drug effects , Neurofibrils/pathology , Neuronal Plasticity/drug effects , Neuronal Plasticity/physiology , Neurons/drug effects , Neurons/pathology , Protein Structure, Tertiary/drug effects , Protein Structure, Tertiary/physiology , Rats , Synapses/drug effects , Synapses/metabolism , Synapses/pathology , Synaptophysin/drug effects , Synaptophysin/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...